North Dakota State Investment Board Takes Position in Agilent Technologies, Inc. $A

North Dakota State Investment Board purchased a new stake in Agilent Technologies, Inc. (NYSE:A) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 9,773 shares of the medical research company’s stock, valued at approximately $1,330,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Brighton Jones LLC boosted its holdings in shares of Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after acquiring an additional 270 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of Agilent Technologies by 15.9% during the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after acquiring an additional 769 shares in the last quarter. Geneos Wealth Management Inc. boosted its holdings in shares of Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after acquiring an additional 212 shares in the last quarter. Acadian Asset Management LLC boosted its holdings in shares of Agilent Technologies by 16.5% during the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after acquiring an additional 758 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in shares of Agilent Technologies during the 2nd quarter valued at $273,000.

Agilent Technologies Stock Down 1.5%

Shares of A opened at $110.43 on Wednesday. The company has a market capitalization of $31.21 billion, a PE ratio of 24.38, a PEG ratio of 2.36 and a beta of 1.22. Agilent Technologies, Inc. has a 12 month low of $107.07 and a 12 month high of $160.27. The stock’s 50-day moving average price is $114.85 and its two-hundred day moving average price is $130.10. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same period last year, the business posted $1.31 earnings per share. The business’s revenue was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on A shares. Morgan Stanley cut their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. UBS Group cut their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Wells Fargo & Company cut their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a report on Thursday, February 26th. Wall Street Zen downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Finally, HSBC started coverage on Agilent Technologies in a report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price objective on the stock. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies has an average rating of “Buy” and an average price target of $163.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.